Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0XM4G
|
||||
Former ID |
DIB010823
|
||||
Drug Name |
Bindarit
|
||||
Synonyms |
Bindarit, Angelini Pharmaceuticals; CCL2 inhibitor (inflammatory disorders/kidney disease), Angelini Pharmaceuticals; MCP-1 inhibitor (inflammatory disorder/kidney disease), Angelini Pharmaceuticals
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Nephritis [ICD10:N00-N19, N25-N29] | Phase 3 | [531744] | ||
Company |
Angelini Pharmaceuticals SpA
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H20N2O3
|
||||
Canonical SMILES |
n1(nc(c2c1cccc2)COC(C(=O)O)(C)C)Cc1ccccc1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | C-C motif chemokine 2 | Target Info | Inhibitor | [531744] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.